Alnylam Pharmaceuticals, Inc.

SIGNATUREFD, LLC ALNY

Report date

3/31/2026

Quarter

2026 Q1

Filed

4/7/2026

Shares

2,047

Value ($000)

677

Weight

0.0%

2019 Q4 - 2026 Q1 (26 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	4/7/2026	677	0.0%	2,047	3/31/2026
2025 Q4	1/20/2026	788	0.0%	1,981	12/31/2025
2025 Q3	10/21/2025	911	0.0%	1,998	9/30/2025
2025 Q2	7/16/2025	622	0.0%	1,906	6/30/2025
2025 Q1	5/2/2025	474	0.0%	1,755	3/31/2025
2024 Q4	2/10/2025	386	0.0%	1,640	12/31/2024
2024 Q3	10/21/2024	510	0.0%	1,854	9/30/2024
2024 Q2	7/29/2024	336	0.0%	1,383	6/30/2024
2024 Q1	5/3/2024	164	0.0%	1,099	3/31/2024
2023 Q4	2/1/2024	228	0.0%	1,189	12/31/2023
2023 Q3	11/3/2023	208	0.0%	1,175	9/30/2023
2023 Q2	8/1/2023	317	0.0%	1,668	6/30/2023
2023 Q1	4/28/2023	289	0.0%	1,445	3/31/2023
2022 Q4	1/30/2023	381	0.0%	1,604	12/31/2022
2022 Q3	11/8/2022	309	0.0%	1,545	9/30/2022
2022 Q2	8/10/2022	71	0.0%	488	6/30/2022
2022 Q1	5/2/2022	163	0.0%	998	3/31/2022
2021 Q4	1/25/2022	157	0.0%	923	12/31/2021
2021 Q3	10/28/2021	180	0.0%	952	9/30/2021
2021 Q2	7/26/2021	159	0.0%	940	6/30/2021
2021 Q1	4/30/2021	114	0.0%	804	3/31/2021
2020 Q4	2/11/2021	124	0.0%	953	12/31/2020
2020 Q3	11/3/2020	70	0.0%	480	9/30/2020
2020 Q2	7/30/2020	35	0.0%	235	6/30/2020
2020 Q1	4/23/2020	21	0.0%	190	3/31/2020
2019 Q4	2/5/2020	6	0.0%	49	12/31/2019